Catto International Limited is a registered limited company operating in the United Kingdom, established in 1998. The company specializes in the distribution and support of pharmaceutical products, with a primary focus on intravenous therapies. Catto International is currently active and maintains a strong presence within the European market. The company’s core business revolves around the supply of Enoxaparin, a vital injectable anticoagulant utilized for the prevention and treatment of blood clots, including DVT (deep vein thrombosis), pulmonary embolism risk, unstable angina, and heart attack. Catto International provides comprehensive dosing guidelines, detailed hemodialysis use instructions, and outlines of key side effects associated with Enoxaparin administration. As a limited company, Catto International operates under the SIC codes – 86900 (Other human health activities) and 96090 (Other service activities n.e.c.). The company’s international presence is currently limited, primarily focused on European distribution. Catto International employs a significant number of skilled workers, indicating a commitment to operational excellence and client service. The company’s key focus is on providing reliable access to pharmaceutical products vital for patient care.

Catto International Limited is a registered limited company operating in the United Kingdom, established in 1998. The company specializes in the distribution and support of pharmaceutical products, with a primary focus on intravenous therapies. Catto International is currently active and maintains a strong presence within the European market. The company’s core business revolves around the supply of Enoxaparin, a vital injectable anticoagulant utilized for the prevention and treatment of blood clots, including DVT (deep vein thrombosis), pulmonary embolism risk, unstable angina, and heart attack. Catto International provides comprehensive dosing guidelines, detailed hemodialysis use instructions, and outlines of key side effects associated with Enoxaparin administration. As a limited company, Catto International operates under the SIC codes – 86900 (Other human health activities) and 96090 (Other service activities n.e.c.). The company’s international presence is currently limited, primarily focused on European distribution. Catto International employs a significant number of skilled workers, indicating a commitment to operational excellence and client service. The company’s key focus is on providing reliable access to pharmaceutical products vital for patient care.